Intelligent Synthetic Biology Center, 291 Daehak-Ro, Yuseong-Gu, Daejeon, 305-701, Korea.
The Key Laboratory of Biotechnology for Medicinal Plant of Jiangsu Province, Jiangsu Normal University, No. 101 Shanghai Road, Xuzhou, Jiangsu, 221116, People's Republic of China.
Appl Microbiol Biotechnol. 2019 Sep;103(17):7003-7015. doi: 10.1007/s00253-019-09951-4. Epub 2019 Jul 9.
Use of recombinant glycosidases is a promising approach for the production of minor ginsenosides, e.g., Compound K (CK) and F, which have potential applications in the food industry. However, application of these recombinant enzymes for food-grade preparation of minor ginsenosides are limited by the lack of suitable expression hosts and low productivity. In this study, Corynebacterium glutamicum ATCC13032, a GRAS strain that has been used extensively for the industrial-grade production of additives for foodstuffs, was employed to express a novel β-glucosidase (MT619) from Microbacterium testaceum ATCC 15829 with high ginsenoside-transforming activity. A cellulose-binding module was additionally fused to the N-terminus of MT619 for immobilization on cellulose, which is an abundant and safe material. Via one-step immobilization, the fusion protein in cell lysates was efficiently immobilized on regenerated amorphous cellulose at a high density (maximum 984 mg/g cellulose), increasing the enzyme concentration by 286-fold. The concentrated and immobilized enzyme showed strong conversion activities against protopanaxadiol- and protopanaxatriol-type ginsenosides for the production of CK and F. Using gram-scale ginseng extracts as substrates, the immobilized enzyme produced 7.59 g/L CK and 9.42 g/L F in 24 h. To the best of our knowledge, these are the highest reported product concentrations of CK and F, and this is the first time that a recombinant enzyme has been immobilized on cellulose for the preparation of minor ginsenosides. This safe, convenient, and efficient production method could also be effectively exploited in the preparation of food-processing recombinant enzymes in the pharmaceutical, functional food, and cosmetics industries.
使用重组糖苷酶是生产低含量人参皂苷(如 CK 和 F)的一种很有前途的方法,这些化合物在食品工业中有潜在的应用。然而,这些重组酶在食品级低含量人参皂苷制备中的应用受到缺乏合适的表达宿主和低生产率的限制。在这项研究中,谷氨酸棒杆菌 ATCC13032 被用作表达来自 Microbacterium testaceum ATCC 15829 的新型β-葡萄糖苷酶(MT619)的宿主,该菌株已被广泛用于食品添加剂的工业级生产,被认为是 GRAS 菌株。此外,还将纤维素结合模块融合到 MT619 的 N 端,用于固定在纤维素上,纤维素是一种丰富且安全的材料。通过一步固定,细胞裂解物中的融合蛋白可以高效地固定在再生无定形纤维素上,密度高(最大 984mg/g 纤维素),酶浓度提高了 286 倍。浓缩和固定化的酶对原人参二醇和原人参三醇型人参皂苷具有很强的转化活性,可用于生产 CK 和 F。使用克级人参提取物作为底物,固定化酶在 24 小时内生产了 7.59g/L CK 和 9.42g/L F。据我们所知,这是 CK 和 F 的最高报道产物浓度,这也是首次将重组酶固定在纤维素上用于制备低含量人参皂苷。这种安全、方便、高效的生产方法也可以有效地用于制药、功能性食品和化妆品行业中食品加工用重组酶的制备。